Citadel Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.5M | Buy |
1,090,738
+994,351
| +1,032% | +$32.3M | 0.01% | 666 |
|
|
2025
Q1 | $3.64M | Sell |
96,387
-45,394
| -32% | -$1.71M | ﹤0.01% | 2036 |
|
|
2024
Q4 | $11.6M | Buy |
141,781
+135,914
| +2,317% | +$11.1M | ﹤0.01% | 1233 |
|
|
2024
Q3 | $670K | Buy |
+5,867
| New | +$670K | ﹤0.01% | 3492 |
|
|
2024
Q2 | – | Sell |
-119
| Closed | -$8.13K | – | 6574 |
|
|
2024
Q1 | $8.13K | Buy |
+119
| New | +$8.13K | ﹤0.01% | 5702 |
|
|
2023
Q4 | – | Sell |
-22,106
| Closed | -$1.13M | – | 6465 |
|
|
2023
Q3 | $1.13M | Buy |
+22,106
| New | +$1.13M | ﹤0.01% | 2929 |
|
|
2023
Q2 | – | Sell |
-854,110
| Closed | -$32M | – | 6294 |
|
|
2023
Q1 | $32M | Buy |
854,110
+2,252
| +0.3% | +$84.4K | 0.01% | 630 |
|
|
2022
Q4 | $40.8M | Buy |
851,858
+18,991
| +2% | +$911K | 0.01% | 529 |
|
|
2022
Q3 | $20M | Sell |
832,867
-170,119
| -17% | -$4.08M | ﹤0.01% | 824 |
|
|
2022
Q2 | $21.8M | Buy |
1,002,986
+285,031
| +40% | +$6.2M | 0.01% | 782 |
|
|
2022
Q1 | $17.3M | Buy |
717,955
+635,105
| +767% | +$15.3M | ﹤0.01% | 1011 |
|
|
2021
Q4 | $1.97M | Buy |
82,850
+37,116
| +81% | +$883K | ﹤0.01% | 3082 |
|
|
2021
Q3 | $1.16M | Sell |
45,734
-48,263
| -51% | -$1.23M | ﹤0.01% | 3618 |
|
|
2021
Q2 | $2.12M | Sell |
93,997
-16,840
| -15% | -$379K | ﹤0.01% | 3152 |
|
|
2021
Q1 | $2.19M | Sell |
110,837
-83,974
| -43% | -$1.66M | ﹤0.01% | 3059 |
|
|
2020
Q4 | $5.18M | Buy |
194,811
+142,252
| +271% | +$3.78M | ﹤0.01% | 1736 |
|
|
2020
Q3 | $2.6M | Sell |
52,559
-497,192
| -90% | -$24.5M | ﹤0.01% | 2036 |
|
|
2020
Q2 | $17.4M | Buy |
+549,751
| New | +$17.4M | 0.01% | 811 |
|